N-terminally acetylated Endomorphin-1 is a modified Endomorphin-1.
N-terminally acetylated Endomorphin-1 is a synthetic peptide derivative characterized by the acetylation of its N-terminal tyrosine residue. This biochemical modification imparts enhanced metabolic stability and altered receptor interactions compared to the native Endomorphin-1 sequence. As a member of the endogenous opioid peptide family, it is structurally optimized for studies of opioid receptor selectivity, signal transduction, and peptide-receptor dynamics. Its unique structural attributes make it a valuable tool for probing the fundamental mechanisms underlying opioid-mediated physiological processes, as well as for advancing peptide-based research methodologies in neurobiology and pharmacology.
Receptor Binding Studies: The acetylated variant of Endomorphin-1 is widely applied in receptor binding assays to evaluate affinity and selectivity towards the mu-opioid receptor. The N-terminal acetylation can influence both the binding kinetics and receptor activation profile, enabling researchers to dissect the contributions of terminal modifications to ligand-receptor interactions. Utilizing this peptide in in vitro systems allows for precise quantification of binding parameters, aiding the characterization of receptor subtypes and the development of structure-activity relationships within the opioid peptide family.
Peptide Stability Assessment: Incorporation of an acetyl group at the N-terminus is known to confer increased resistance to aminopeptidase-mediated degradation. Scientists employ this modified peptide to investigate the impact of N-terminal acetylation on peptide half-life and metabolic fate in biological matrices. Such studies are instrumental in understanding the role of chemical modifications in peptide stability, facilitating the design of analogues with improved pharmacokinetic profiles for research purposes.
Signal Transduction Analysis: The ability of N-terminally acetylated Endomorphin-1 to activate intracellular signaling cascades downstream of opioid receptors makes it a preferred probe in studies of G-protein coupled receptor (GPCR) signaling. Researchers leverage this peptide to monitor second messenger responses, such as cyclic AMP modulation or calcium flux, in cellular systems expressing specific opioid receptor subtypes. These investigations provide mechanistic insights into the efficacy and bias of peptide ligands in activating divergent intracellular pathways.
Peptide Structure-Activity Relationship (SAR) Exploration: The structural modification present in this peptide serves as a model for exploring the relationship between peptide conformation and biological activity. By comparing the functional properties of acetylated versus non-acetylated analogues, researchers can elucidate the influence of terminal modifications on receptor selectivity, potency, and efficacy. These SAR studies are essential for guiding the rational design of novel opioid peptides with tailored properties for research applications.
Analytical Method Development: The distinct physicochemical properties imparted by N-terminal acetylation make this peptide a suitable reference standard or calibration compound in analytical method validation. Laboratories utilize it to optimize chromatographic separation, mass spectrometric detection, and peptide quantification protocols. Its defined structure and stability support the establishment of robust, reproducible analytical workflows for peptide-based assays in biochemical and pharmaceutical research settings.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More